Life sciences
Lithuanian IT specialists are contributing to a genetic research platform
Feb 4, 2021
Life Sciences
A growth hotspot in Europe for Life Sciences development and operations
Lithuania’s Life Sciences sector is gaining prominence. Boosted by an integrated network of science valleys and educational institutions that supply businesses with a pool of top-notch talent that is eager to learn, the sector is accelerating faster than almost anywhere else in Europe.
Life Sciences companies in Lithuania are among the most profitable in the country, with 90% of their output exported worldwide, yet the market remains unsaturated.
Lithuania’s life sciences sector at a glance
72
the total number of Life Science companies present
>1%
percentage of Lithuania‘s GDP generated by the sector
16th
in the Global Innovation in Biotechnology ranking
90%
percentage of all pharmaceutical and healthcare production exported, with produce going to over 100 countries
Priority sector
Life Sciences is high on the political agenda, which means we offer exceptional support for soft-landing and are dedicated to deliver.
Source: Lithuania’s Life Sciences Strategy approved by the Parliament, 2018 September
FDA-approved regulatory authorities
In 2018 Lithuania entered into a Mutual Recognition Agreement with the FDA, under which the FDA recognized the Lithuanian State Medicine Control Agency as capable of conducting inspections that meet US requirements.
Source: US Food & Drug Administration, 2018
A range of benefits for Life Sciences companies
1
Attractive financial incentives for both R&D and manufacturing activities
2
Exceptional government support to ensure smooth business operations in the country
3
A pool of highly skilled and motivated talent ready to create added value for your business
4
A welcoming and value-driven ecosystem, with support available to ensure a fast and efficient soft-landing
Life Sciences in Lithuania
Main competencies in Lithuania’s ecosystem:
- Cell & gene therapy
- Proteins
- Pharma / drug delivery
- Medtech, including 3D printing, sensors and engineering
Emerging Life Sciences competencies:
- Immunotherapy products
- Biosimilars
- Generics
- Antibodies
- Nucleid acid drugs
Financial incentives and government support
Financial incentives available to Life Sciences companies:
3 Times Deductable Expenses
Patent Box
EU support
Free Economic Zones
Dedicated support from Invest Lithuania
Decision making
Business establishment
Aftercare
Contact us for information about the market or reach out to get intros to local and international partners
